- Home
- IPHA vs EAF Comparison
IPHA vs EAF Comparison
Compare IPHA & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- EAF
- Stock Information
- Founded
- IPHA 1999
- EAF 1886
- Country
- IPHA France
- EAF United States
- Employees
- IPHA N/A
- EAF N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- EAF Industrial Machinery/Components
- Sector
- IPHA Health Care
- EAF Energy
- Exchange
- IPHA Nasdaq
- EAF Nasdaq
- Market Cap
- IPHA 160.1M
- EAF 164.5M
- IPO Year
- IPHA 2019
- EAF 1995
- Fundamental
- Price
- IPHA $2.38
- EAF $0.71
- Analyst Decision
- IPHA Strong Buy
- EAF Hold
- Analyst Count
- IPHA 1
- EAF 6
- Target Price
- IPHA $11.00
- EAF $1.68
- AVG Volume (30 Days)
- IPHA 31.8K
- EAF 2.6M
- Earning Date
- IPHA 03-27-2025
- EAF 04-25-2025
- Dividend Yield
- IPHA N/A
- EAF N/A
- EPS Growth
- IPHA N/A
- EAF N/A
- EPS
- IPHA N/A
- EAF N/A
- Revenue
- IPHA $20,831,349.00
- EAF $514,037,000.00
- Revenue This Year
- IPHA $209.83
- EAF $0.09
- Revenue Next Year
- IPHA $83.96
- EAF $23.33
- P/E Ratio
- IPHA N/A
- EAF N/A
- Revenue Growth
- IPHA N/A
- EAF N/A
- 52 Week Low
- IPHA $1.29
- EAF $0.52
- 52 Week High
- IPHA $3.51
- EAF $2.53
- Technical
- Relative Strength Index (RSI)
- IPHA 71.42
- EAF 50.23
- Support Level
- IPHA $2.13
- EAF $0.57
- Resistance Level
- IPHA $2.34
- EAF $0.81
- Average True Range (ATR)
- IPHA 0.14
- EAF 0.09
- MACD
- IPHA 0.04
- EAF 0.03
- Stochastic Oscillator
- IPHA 90.07
- EAF 60.65
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About EAF GrafTech International Ltd.
GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.